Nephros Corp - רווח נקי למניה בארבעת הרבעונים האחרונים NEPH

Nephros, Inc. (NEPH) provides dialysis clinics with proprietary ultrafiltration systems, creating significant barriers to entry for competitors due to stringent FDA oversight. The business relies on a streamlined delivery of consumables to hospitals to maintain patient safety. The confirmed price history on the EPS (TTM) chart, equal to 25.80, is complemented by the optimization of US-based assembly, which completely offsets the risks of port delays.
NEPH (Nephros): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator measures the dynamics of the rolling annual earnings per share, allowing for an assessment of business resilience to market shocks through the rate of change in net yield. By analyzing this chart of EPS YoY ttm growth rates, an investor can see the margin of safety for Nephros, Inc. (NEPH), which is supported by regular purchases of ultrafiltration systems by medical centers to combat infections.